{
    "eid": "2-s2.0-85078900629",
    "title": "Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)",
    "cover-date": "2020-04-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "chronic myeloid leukaemia",
        "imatinib",
        "long-term data",
        "newly diagnosed",
        "radotinib"
    ],
    "authors": [
        "Young Rok Do",
        "Jae Yong Kwak",
        "Jeong A. Kim",
        "Hyeoung Joon Kim",
        "Joo Seop Chung",
        "Ho Jin Shin",
        "Sung Hyun Kim",
        "Udomsak Bunworasate",
        "Chul Won Choi",
        "Dae Young Zang",
        "Suk Joong Oh",
        "Saengsuree Jootar",
        "Ary Harryanto Reksodiputro",
        "Won Sik Lee",
        "Yeung Chul Mun",
        "Jee Hyun Kong",
        "Priscilla B. Caguioa",
        "Hawk Kim",
        "Jinny Park",
        "Dong Wook Kim"
    ],
    "citedby-count": 15,
    "ref-count": 23,
    "ref-list": [
        "Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet",
        "European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013",
        "Application of systematic coronary risk evaluation chart to identify chronic myeloid leukemia patients at risk of cardiovascular diseases during nilotinib treatment",
        "Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia: results from the 24-month follow-up of the BELA trial",
        "A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias",
        "Final 5-year study results of DASISION: the dasatinib versus imatinib study in treatment-na\u00efve chronic myeloid leukemia patients trial",
        "Pleural effusion in dasatinib-treated patients with chronic myeloid leukemia in chronic phase: identification and management",
        "Treatment-free remission with first- and second-generation tyrosine kinase inhibitors",
        "Cardiovascular complications of targeted therapies for chronic myeloid leukemia",
        "The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts",
        "Chronic myeloid leukemia: second-line drugs of choice",
        "Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial",
        "Long-term outcomes of imatinib treatment for chronic myeloid leukemia",
        "Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial",
        "Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring",
        "Cumulative incidence in competing risks data and competing risks regression analysis",
        "Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors",
        "Phase III clinical trial (RERISE study) results of efficacy and safety of radotinib compared with imatinib in newly diagnosed chronic phase chronic myeloid leukemia",
        "Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up",
        "Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial",
        "Long-term BCR-ABL1 tyrosine kinase inhibitor therapy in chronic myeloid leukemia",
        "Treatment-free remission after two-year consolidation therapy with nilotinib in patients with chronic myeloid leukemia: STAT2 trial in Japan",
        "Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1"
    ],
    "affiliation": [
        {
            "affiliation-city": "Suwon",
            "@id": "60277007",
            "affilname": "The Catholic University of Korea, St. Vincent's Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60277007",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60212058",
            "affilname": "Korea University Guro Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60212058",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Busan",
            "@id": "60211908",
            "affilname": "Pusan National University Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60211908",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seongnam",
            "@id": "60199632",
            "affilname": "Gachon University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199632",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Wonju",
            "@id": "60115404",
            "affilname": "Wonju Severance Christian Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115404",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Daegu",
            "@id": "60094606",
            "affilname": "Keimyung University, Dongsan Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60094606",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60081368",
            "affilname": "Inje University Paik Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60081368",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Central Jakarta",
            "@id": "60069378",
            "affilname": "Universitas Indonesia, RSUPN Dr. Cipto Mangunkusumo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069378",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60030358",
            "affilname": "Ewha Womans University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030358",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chuncheon",
            "@id": "60018986",
            "affilname": "Hallym University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018986",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Jeonju",
            "@id": "60016650",
            "affilname": "Jeonbuk National University, School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016650",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60016329",
            "affilname": "SKKU School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016329",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Busan",
            "@id": "60016209",
            "affilname": "Dong-A University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016209",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Gwangju",
            "@id": "60007215",
            "affilname": "Chonnam National University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007215",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Bucheon-si",
            "@id": "60003087",
            "affilname": "The Catholic University of Korea",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003087",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Quezon City",
            "@id": "112643991",
            "affilname": "St. Luke\u2019s Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112643991",
            "affiliation-country": "Philippines"
        }
    ],
    "funding": [
        "Korea Leukemia Bank"
    ]
}